	US 12,215,136 B2
	Exosome for stimulating T cell and pharmaceutical use thereof
Tai Gyu Kim, Seoul (KR); Hyun Jung Sohn, Seoul (KR); and Su Eon Kim, Yongin-si (KR)
Assigned to The Catholic University of Korea Industry—Academic Cooperation Foundation, Seoul (KR)
Filed by THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION, Seoul (KR)
Filed on Apr. 4, 2023, as Appl. No. 18/295,631.
Application 18/295,631 is a division of application No. 16/465,919, granted, now 11,649,436, previously published as PCT/KR2017/013981, filed on Dec. 1, 2017.
Claims priority of application No. 10-2016-0163822 (KR), filed on Dec. 2, 2016.
Prior Publication US 2023/0287347 A1, Sep. 14, 2023
Int. Cl. A61K 8/14 (2006.01); A61K 9/127 (2006.01); A61K 39/00 (2006.01); C07K 14/705 (2006.01); C07K 14/715 (2006.01); C07K 14/735 (2006.01); C07K 14/74 (2006.01); C12N 5/0783 (2010.01)

CPC C07K 14/70535 (2013.01) [A61K 39/4611 (2023.05); A61K 39/464453 (2023.05); A61K 39/464491 (2023.05); A61K 39/464838 (2023.05); C07K 14/70532 (2013.01); C07K 14/70539 (2013.01); C07K 14/70596 (2013.01); C07K 14/7151 (2013.01); C12N 5/0636 (2013.01); C12N 5/0638 (2013.01); C12N 2501/25 (2013.01); C12N 2501/51 (2013.01); C12N 2501/599 (2013.01)]

10 Claims

1. An exosome which expresses a human leukocyte antigen (HLA), CD32, CD80, CD83, and 4-1BBL.